FOUR LAB-MADE PEPTIDES, ONE UNTESTED BLEND
KLOW peptide combines four short protein chains. No study has examined that exact mixture.
You'll see what researchers found about KPV, GHK-Cu, BPC-157 and TB-500. You'll also see where the facts stop, so you can judge each claim clearly.
Each part began with a different research question
The names on a KLOW label began in separate labs. Teams made KPV, GHK-Cu, BPC-157, and TB-500 for different repair questions. A seller later packed the compounds together and named the vial KLOW peptide. That mixture still awaits a fair comparison.
KPV work dealt with soreness in your gut and your immune cells. GHK-Cu carries copper and may help your skin make collagen. Most BPC-157 work used animals with cut tendons or poor blood flow. TB-500 comes from thymosin beta-4, a protein involved when cells cross wounds.
You won't find FDA clearance for any of these compounds in people. One-part findings can't show you how the mixture acts. Picture four tools sharing your toolbox. Knowing each tool won't tell you how well the set performs.
We sort the separate findings so you can follow them. We also mark each question that science hasn't answered. The effects page gives you people's reports, including unwanted changes. Personal reports don't carry the weight of a controlled trial.
What is KLOW peptide: four parts in one vial
Peptides are small protein chains. KLOW peptide mixes four of them in dried form. One usual research vial totals 80 mg. That total describes the material, not a dose for you.
The vial holds GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, and KPV 10 mg. The copper part makes up 62.5% of the vial. In plain terms, almost two-thirds of the powder is GHK-Cu.
KPV uses three amino acids, tiny units your body links into protein. GHK-Cu pairs those units with copper at a 1:1 match. Its other name is Copper Tripeptide-1. BPC-157 is a stomach-protein section made from fifteen protein units.
The 157 in that name isn't a dose. TB-500 comes from thymosin beta-4, a longer wound protein. The klow stack isn't approved medicine. Separate findings may interest you, but only a test of the whole mix could answer your question.
KLOW is the name of this four-part blend
KLOW isn't a set of initials. It's simply the blend's name. GLOW has GHK-Cu, BPC-157, and TB-500 but leaves out KPV. WOLVERINE is another mix made for another aim.
The FDA hasn't cleared any KLOW part for use in people. It hasn't cleared the four-part mix either. The world sports agency bans thymosin beta-4, the source of TB-500, for tested athletes [1][2]. The ban applies at all times.
The FDA put BPC-157 in category 2 during a pharmacy review. That group lacked enough proof for safe and useful mixing. The label isn't approval for human use. These facts matter if you face sport tests or weigh treatment.
The KLOW blend parts act in different ways
KPV slowed the cell work that drives gut swelling [3]. Sore gut cells also drew more KPV inside. The test used 160 micromolar, which tells how strong the test liquid was [3]. That number doesn't give you a useful dose.
GHK-Cu made repair cells produce more collagen [4][5]. Collagen is the strong protein that gives strength to your skin and tendons. Copper helped bind those fibers into tougher tissue [4]. A dish of cells can't show what KLOW does in you.
Tiny blood vessels formed after BPC-157 in lab tests. Its full lab name ends with receptor 2, meaning a cell part that starts vessel growth. Blood returned sooner to rat muscle with poor flow [6][7].
TB-500 comes from the longer wound protein thymosin beta-4. That protein helped cells move over an open wound [8]. Researchers haven't shown the shorter part acts alike. That leaves you with far less proof for it.
Each substance did different work in separate tests. Nobody has checked those actions in one mix. You can follow each result without calling KLOW proved. Scientists still haven't tried the finished blend in a fair study.
KLOW peptide benefits come from separate studies
KLOW peptide benefits come from four separate study records. A trial of KLOW didn't produce them for you. KPV, GHK-Cu, BPC-157, and TB-500 each need their own line. Keep that split in mind when judging the mix.
The clearest BPC-157 result used rat Achilles tendons cut through. Treated rats regained more strength and laid collagen in better order [9]. Another BPC-157 test found faster blood return to a poorly fed leg [6]. People like you weren't part of either test.
Researchers also tested full thymosin beta-4, a protein with forty-three building blocks. New skin covered 42% more rat wound at 4 days. The gain reached 61% at 7 days. After 10 picograms were added, dish-kept skin cells moved farther [8].
A trillion picograms together weigh one gram. TB-500 is one small section of the longer protein. Results from the full protein don't prove the short piece works alike. Work aimed at TB-500 is still thin. That leaves you with much less sure ground.
KPV entered sore gut cells and slowed the work behind swelling. It also eased colitis, or long swelling in the colon, in mice [3]. Those results came from dishes and mice. They don't tell you what happens in a person.
GHK-Cu was rubbed on women's skin. Collagen rose in 70% of them. The result was 50% with vitamin C and 40% with retinoic acid [4]. Their skin also became firmer, with fewer and shallower lines.
In lab cells, GHK changed about 31% of the instructions used to make protein. The team counted only changes of half or more [5]. Some involved DNA repair and protection from cell wear. The KLOW effects page shows you which items are personal reports and which came from studies.
KLOW side effects are not well tested
A controlled safety test of KLOW doesn't exist. Each warning begins with one ingredient. Your doctor would still face wide gaps. Silence about harm isn't the same as safety.
TB-500/thymosin beta-4 falls under WADA's S2 rule [1][2]. Tested athletes face a ban at all times. That rule can affect you even without a plan to gain an edge. Your intent won't change the list.
Three parts may spur new vessel growth. They include BPC-157, the thymosin beta-4 piece, and GHK-Cu. Tumors need blood vessels too. That fact raises concern with recent or active cancer [6][10].
Neither BPC-157 nor TB-500 has settled the cancer question. Whole-body blend tests are also missing. The warning comes from how the compounds act. It doesn't prove that you will be harmed.
One small test put BPC-157 into the veins of two healthy adults. The amount rose to 20 mg. Thyroid, kidney, blood sugar, heart, and liver checks didn't change [10]. No bad event appeared, but two volunteers can't settle your safety.
A 2026 Sports Medicine review examined unapproved peptides. The list included TB-500 and BPC-157. Its authors saw promising animal work but scant strong human safety work [2]. They also described weak oversight.
Read the full cautions beside the KLOW references. The KLOW effects page gives you accounts from people. Those accounts aren't controlled trial results. Researchers haven't checked them as proof.